Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Druyts

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 28, 2018
Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect ComparisonsChakrapani Balijepalli, Rohan Shirali, Prashanth Kandaswamy, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 7, 2018
Correction to: Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect ComparisonsChakrapani Balijepalli, Rohan Shirali, Prashanth Kandaswamy, et al.
Targeted Oncology|May 6, 2025
Efficacy of First-Line Treatments for Advanced Renal Cell Carcinoma: A Bayesian Network Meta-analysis of Objective Response, Progression-Free Survival, and Overall SurvivalManuela Schmidinger, Pratik P Rane, Kevin Yan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2012
Efficacy and safety of pegylated interferon alfa-2a or alfa-2b plus ribavirin for the treatment of chronic hepatitis C in children and adolescents: a systematic review and meta-analysisEric Druyts, Kristian Thorlund, Ping Wu, et al.
Melanoma Research|October 12, 2022
Resistance to anti-PD1 therapies in patients with advanced melanoma: systematic literature review and application of the Society for Immunotherapy of Cancer Immunotherapy Resistance Taskforce anti-PD1 resistance definitionsIrene M Shui, Emilie Scherrer, Andrew Frederickson, et al.
Cephalalgia : an International Journal of Headache|October 11, 2013
Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysisKristian Thorlund, Edward J Mills, Ping Wu, et al.
Journal of Child Neurology|June 26, 2019
A Review of Available Treatments, Clinical Evidence, and Guidelines for Diagnosis and Treatment of Pediatric Multiple Sclerosis in the United StatesLauren B Krupp, Maria Cecilia Vieira, Haley Toledano, et al.
Schizophrenia Research and Treatment|May 29, 2018
Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-AnalysisChakrapani Balijepalli, Eric Druyts, Michael J Zoratti, et al.
International Journal of Epidemiology|November 23, 2012
Cohort profile: the MUg Observational CohortAnna Funk, Steve Kanters, Margaret Nansubuga, et al.
Immunotherapy|November 6, 2019
Reslizumab and mepolizumab for moderate-to-severe poorly controlled asthma: an indirect comparison meta-analysisKevin Yan, Chakrapani Balijepalli, Rohini Sharma, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 28, 2018
Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect ComparisonsChakrapani Balijepalli, Rohan Shirali, Prashanth Kandaswamy, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 7, 2018
Correction to: Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect ComparisonsChakrapani Balijepalli, Rohan Shirali, Prashanth Kandaswamy, et al.
Targeted Oncology|May 6, 2025
Efficacy of First-Line Treatments for Advanced Renal Cell Carcinoma: A Bayesian Network Meta-analysis of Objective Response, Progression-Free Survival, and Overall SurvivalManuela Schmidinger, Pratik P Rane, Kevin Yan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2012
Efficacy and safety of pegylated interferon alfa-2a or alfa-2b plus ribavirin for the treatment of chronic hepatitis C in children and adolescents: a systematic review and meta-analysisEric Druyts, Kristian Thorlund, Ping Wu, et al.
Melanoma Research|October 12, 2022
Resistance to anti-PD1 therapies in patients with advanced melanoma: systematic literature review and application of the Society for Immunotherapy of Cancer Immunotherapy Resistance Taskforce anti-PD1 resistance definitionsIrene M Shui, Emilie Scherrer, Andrew Frederickson, et al.
Cephalalgia : an International Journal of Headache|October 11, 2013
Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysisKristian Thorlund, Edward J Mills, Ping Wu, et al.
Journal of Child Neurology|June 26, 2019
A Review of Available Treatments, Clinical Evidence, and Guidelines for Diagnosis and Treatment of Pediatric Multiple Sclerosis in the United StatesLauren B Krupp, Maria Cecilia Vieira, Haley Toledano, et al.
Schizophrenia Research and Treatment|May 29, 2018
Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-AnalysisChakrapani Balijepalli, Eric Druyts, Michael J Zoratti, et al.
International Journal of Epidemiology|November 23, 2012
Cohort profile: the MUg Observational CohortAnna Funk, Steve Kanters, Margaret Nansubuga, et al.
Immunotherapy|November 6, 2019
Reslizumab and mepolizumab for moderate-to-severe poorly controlled asthma: an indirect comparison meta-analysisKevin Yan, Chakrapani Balijepalli, Rohini Sharma, et al.
Pageof 7